The IDE approval marks a pivotal milestone for Aqua Medical, allowing the company to begin enrolling patients in the U.S. RESTORE-1 pilot trial and study PIMA's potential to deliver durable metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback